• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications.
BackgroundRecombinant human (rh) interferon alpha2a (IFN-α2a) therapy is successfully used for the treatment of Behçet’s disease (BD) uveitis refractory to conventional immunosuppressive treatment.(More)